No Data
No Data
Guangzhou Baiyunshan Pharmaceutical Holdings' (HKG:874) Weak Earnings May Only Reveal A Part Of The Whole Picture
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
baiyunshan ph (00874) subsidiary "Pharmaceutical Production License" change
baiyunshan (00874) announced that its subsidiary Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd. (hereinafter referred to as...
Baiyunshan (00874): Cefoperazone Sodium for Injection and Oxytocin Injection passed the generic drug quality and efficacy consistency evaluation.
Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., Baiyunshan Pharmaceutical...
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Share Price Is Matching Sentiment Around Its Earnings
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024
No Data
No Data